Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 23, 2017
What are the generic drug sources for cimetidine and what is the scope of cimetidine patent protection?
Cimetidine is the generic ingredient in seven branded drugs marketed by Sandoz, Ivax Sub Teva Pharms, Upsher-smith Labs, Watson Labs Inc, Glaxosmithkline, Sandoz Inc, Watson Labs Teva, Chartwell Molecules, Medtech Products, Dava Pharms Inc, Mylan, Apotex, Teva, Contract Pharmacal, Cycle Pharms Ltd, Pliva, Perrigo, L Perrigo Co, Vintage Pharms Llc, Ani Pharms Inc, Hospira, Teva Parenteral, Luitpold, Pharm Assoc, Wockhardt, Apotex Inc, Hi Tech Pharma, and G And W Labs Inc, and is included in fifty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 7 |
| Patents: | 1 |
| Applicants: | 28 |
| NDAs: | 56 |
| Drug Master File Entries: see list | 25 |
| Suppliers / Packagers: see list | 34 |
| Bulk Api Vendors: see list | 101 |
| Clinical Trials: see list | 47 |
| Patent Applications: see list | 6,593 |
| Therapeutic Class: | Gastrointestinal Agents |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | cimetidine at DailyMed |
| Drug Class | Histamine-2 Receptor Antagonist |
| Mechanism of Action | Histamine H2 Receptor Antagonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | CIMETIDINE | cimetidine | TABLET;ORAL | 074246-003 | May 17, 1994 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Watson Labs Inc | CIMETIDINE | cimetidine | TABLET;ORAL | 074316-001 | Feb 28, 1996 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Hospira | CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 074468-005 | Dec 29, 1994 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Vintage Pharms Llc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 074251-001 | Dec 22, 1994 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Apotex Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 075560-001 | Mar 15, 2000 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-004 | Dec 14, 1983 | 3,950,333 | ► Subscribe | ||||||||||||||||||||||
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-004 | Dec 14, 1983 | 4,024,271 | ► Subscribe | ||||||||||||||||||||||
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-002 | Approved Prior to Jan 1, 1982 | 3,950,333 | ► Subscribe | ||||||||||||||||||||||
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-005 | Apr 30, 1986 | 3,950,333 | ► Subscribe | ||||||||||||||||||||||
Glaxosmithkline | TAGAMET | cimetidine | TABLET;ORAL | 017920-003 | Approved Prior to Jan 1, 1982 | 3,950,333 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,083 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
